What are the major opportunities in the Asthma Drugs market? What are the strategies for the Asthma Drugs market?

For detailed insights on the major opportunities and strategies in the Asthma Drugs market, Read More

How does the Asthma Drugs market relate to the overall economy and other similar markets?

For detailed insights on Asthma Drugs's relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Asthma Drugs market growth? SWOT analysis of the Asthma Drugs market.

For detailed insights on the key dynamics influencing the Asthma Drugs market growth and SWOT analysis of the Asthma Drugs industry, Read More

Asthma Drugs Market Global Report 2026 Market Report Infographic Image

Item added to cart!

Published : February 2026

Pages :

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Purchase This Report Download Sample PDF

Purchase This Report

Asthma Drugs Market Report 2026

Name: Asthma Drugs Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma), By Therapy (Preventive), By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End-User (Asthma Patients) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Asthma Drugs Market Overview

• Asthma Drugs market size has reached to $24.93 billion in 2025

• Expected to grow to $33.62 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Rising Prevalence Of Respiratory Diseases Fuels Growth In The Asthma Drug Market

• Market Trend: Product Innovation In The Asthma Drug Market With Launch Of Indacaterol Plus Mometasone

• North America was the largest region in 2025 and Asia Pacific is the fastest growing region.

What Is Covered Under Asthma Drugs Market?

Asthma refers to a chronic lung disease that is caused by the inflammation and tightening of muscles around the airways, which makes patients suffer from effective breathing. This is caused when the airways get narrow, swollen, and blocked by excess mucus. Asthma drugs play a crucial role in managing asthma.

The main types of asthma are allergic and non-allergic. Allergic asthma is a respiratory condition characterized by the constriction of airways upon exposure to an allergen, leading to difficulty in breathing. These are various trigger types for asthma such as adult-onset asthma, child-onset asthma, cough-induced asthma, exercise-induced asthma, occupational asthma, nocturnal asthma, and steroid-resistant asthma. Asthma drug are classified into classes such as bronchodilators, monoclonal antibodies, anti-inflammatory drugs, and combination drugs that are used by asthma patients and COPD patients.

Asthma Drugs Market Global Report 2026 Market Report bar graph

What Is The Asthma Drugs Market Size and Share 2026?

The asthma drugs market size has grown strongly in recent years. It will grow from $24.93 billion in 2025 to $26.3 billion in 2026 at a compound annual growth rate (CAGR) of 5.5%. The growth in the historic period can be attributed to rising prevalence of asthma, limited access to advanced therapies, high incidence of respiratory infections, traditional inhaler usage, awareness campaigns by health organizations.

What Is The Asthma Drugs Market Growth Forecast?

The asthma drugs market size is expected to see strong growth in the next few years. It will grow to $33.62 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to growth in biologics & monoclonal antibodies, adoption of smart inhalers, digital health integration, expansion of preventive care programs, increasing pediatric asthma diagnosis. Major trends in the forecast period include personalized asthma treatment, telemedicine & remote patient monitoring, development of biologic and targeted therapies, inhalation device innovation, increased focus on pediatric asthma care.

Book your 30 minutes free consultation with our research experts

Global Asthma Drugs Market Segmentation

1) By Type Of Asthma: Allergic, Non-Allergic

2) By Asthma Trigger Type: Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

3) By Therapy: Preventive

4) By Drug Class: Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

5) By End-User: Asthma Patients

Subsegments:

1) By Allergic: Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

2) By Non-Allergic: Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

What Is The Driver Of The Asthma Drugs Market?

The rising prevalence of respiratory diseases will boost the asthma drug market. Respiratory diseases are medical conditions that affect the respiratory system, which includes the lungs, bronchi, trachea, larynx, pharynx, and nasal passages. The prevalence of respiratory diseases drives the use of asthma drugs to manage and alleviate symptoms associated with respiratory conditions. As respiratory diseases become more widespread, particularly conditions like asthma characterized by chronic inflammation and airway constriction, the demand for effective therapeutic interventions increases. For instance, in December 2023, according to a research study published by JAMA Network Open, a medical journal by the American Medical Association, the global burden of chronic obstructive pulmonary disease (COPD) projected that the cases worldwide could reach nearly 600 million by 2050, marking a 23% increase in prevalence. Therefore, the rising prevalence of respiratory diseases will drive the asthma drug industry forward.

Key Players In The Global Asthma Drugs Market

Major companies operating in the asthma drugs market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd., Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc.

Global Asthma Drugs Market Trends and Insights

Major companies operating in the asthma drug market are focused on product innovation, such as fixed-dose triple-drug combinations, to improve lung function, better manage symptoms, and reduce exacerbations in patients with uncontrolled asthma. Fixed-dose triple-drug combinations combine multiple therapeutic agents into a single inhalation therapy to enhance treatment adherence and efficacy. For instance, in January 2023, Lupin Ltd., an India-based pharmaceutical company, launched DIFIZMA, a fixed-dose combination of indacaterol, glycopyrronium, and mometasone, for the management of inadequately controlled asthma in adults and adolescents twelve years and older. Approved by the Drug Controller General of India (DCGI), DIFIZMA expanded Lupin’s respiratory portfolio as the only fixed-dose triple-drug combination for asthma patients requiring improved symptom control. Lupin specializes in developing and manufacturing a wide range of pharmaceutical products, including inhalation therapies for respiratory disorders.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Asthma Drugs Market?

In February 2024, GSK plc, a UK-based pharmaceutical industry company, acquired Aiolos Bio for an undisclosed amount. Through this acquisition, GSK gains access to AIO 001, a potentially best-in-class, long-acting anti-TSLP monoclonal antibody that is ready to enter Phase II clinical development for the treatment of adult patients with asthma. AIO-001’s long half-life could allow dosing every six months, potentially redefining the standard of care, especially for the ~40% of severe asthma patients with low T2 inflammation. Aiolos Bio is a US-based clinical-stage biotech company working on a drug for asthma.

Regional Insights

North America was the largest region in the asthma drugs market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Asthma Drugs Market?

The asthma drugs market consists of sales of drugs such as bronchodilators (beta-2 agonists), monoclonal antibodies (omalizumab, mepolizumab), and anti-inflammatory drugs (budesonide, ciclesonide), used for the treatment of asthma in patients of all ages. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Asthma Drugs Market Report 2026?

The asthma drugs market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the asthma drugs industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abhilash Pyata

Asthma Drugs Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$26.3 billion
Revenue Forecast In 2035	$33.62 billion
Growth Rate	CAGR of 5.5% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Type Of Asthma, Asthma Trigger Type, Therapy, Drug Class, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Asthma Drugs Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Asthma Drugs Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Asthma Drugs Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Asthma Drugs Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Digitalization, Cloud, Big Data & Cybersecurity

4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Artificial Intelligence & Autonomous Intelligence

4.2. Major Trends

4.2.1 Personalized Asthma Treatment

4.2.2 Telemedicine & Remote Patient Monitoring

4.2.3 Development Of Biologic And Targeted Therapies

4.2.4 Inhalation Device Innovation

4.2.5 Increased Focus On Pediatric Asthma Care

5. Asthma Drugs Market Analysis Of End Use Industries

5.1 Asthma Patients

5.2 Copd Patients

5.3 Pediatric Patients

5.4 Geriatric Patients

5.5 Healthcare Providers

6. Asthma Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Asthma Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Asthma Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Asthma Drugs Market Size, Comparisons And Growth Rate Analysis

7.3. Global Asthma Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Asthma Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Asthma Drugs Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Asthma Drugs Market Segmentation

9.1. Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Allergic, Non-Allergic

9.2. Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational Asthma, Nocturnal Asthma, Steroid-Resistant Asthma

9.3. Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Preventive

9.4. Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs

9.5. Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Asthma Patients

9.6. Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Inhaled Corticosteroids (ICS), Leukotriene Receptor Antagonists (LTRAs), Monoclonal Antibodies

9.7. Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Short-Acting Beta Agonists (SABAs), Long-Acting Beta Agonists (LABAs), Oral Corticosteroids

10. Asthma Drugs Market Regional And Country Analysis

10.1. Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Asthma Drugs Market

11.1. Asia-Pacific Asthma Drugs Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Asthma Drugs Market

12.1. China Asthma Drugs Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Asthma Drugs Market

13.1. India Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Asthma Drugs Market

14.1. Japan Asthma Drugs Market Overview

14.2. Japan Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Asthma Drugs Market

15.1. Australia Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Asthma Drugs Market

16.1. Indonesia Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Asthma Drugs Market

17.1. South Korea Asthma Drugs Market Overview

17.2. South Korea Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Asthma Drugs Market

18.1. Taiwan Asthma Drugs Market Overview

18.2. Taiwan Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Asthma Drugs Market

19.1. South East Asia Asthma Drugs Market Overview

19.2. South East Asia Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Asthma Drugs Market

20.1. Western Europe Asthma Drugs Market Overview

20.2. Western Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Asthma Drugs Market

21.1. UK Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Asthma Drugs Market

22.1. Germany Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Asthma Drugs Market

23.1. France Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Asthma Drugs Market

24.1. Italy Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Asthma Drugs Market

25.1. Spain Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Asthma Drugs Market

26.1. Eastern Europe Asthma Drugs Market Overview

26.2. Eastern Europe Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Asthma Drugs Market

27.1. Russia Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Asthma Drugs Market

28.1. North America Asthma Drugs Market Overview

28.2. North America Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Asthma Drugs Market

29.1. USA Asthma Drugs Market Overview

29.2. USA Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Asthma Drugs Market

30.1. Canada Asthma Drugs Market Overview

30.2. Canada Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Asthma Drugs Market

31.1. South America Asthma Drugs Market Overview

31.2. South America Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Asthma Drugs Market

32.1. Brazil Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Asthma Drugs Market

33.1. Middle East Asthma Drugs Market Overview

33.2. Middle East Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Asthma Drugs Market

34.1. Africa Asthma Drugs Market Overview

34.2. Africa Asthma Drugs Market, Segmentation By Type Of Asthma, Segmentation By Asthma Trigger Type, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Asthma Drugs Market Regulatory and Investment Landscape

36. Asthma Drugs Market Competitive Landscape And Company Profiles

36.1. Asthma Drugs Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Asthma Drugs Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Asthma Drugs Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. AstraZeneca PLC. Overview, Products and Services, Strategy and Financial Analysis

37. Asthma Drugs Market Other Major And Innovative Companies

GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc.

38. Global Asthma Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Asthma Drugs Market

40. Asthma Drugs Market High Potential Countries, Segments and Strategies

40.1 Asthma Drugs Market In 2030 - Countries Offering Most New Opportunities

40.2 Asthma Drugs Market In 2030 - Segments Offering Most New Opportunities

40.3 Asthma Drugs Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Asthma Drugs Market, Overview Of Key Products - Product Examples

Table 2: Global Asthma Drugs Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Asthma Drugs Market, Supply Chain Analysis

Table 4: Global Asthma Drugs Market, Major Raw Material Providers

Table 5: Global Asthma Drugs Market, Major Resource Providers

Table 6: Global Asthma Drugs Market, Major Manufacturers (Suppliers)

Table 7: Global Asthma Drugs Market, Major Distributors And Channel Partners

Table 8: Global Asthma Drugs Market, Key Technologies & Future Trends

Table 9: Global Asthma Drugs Market, Major Trends

Table 10: Global Asthma Drugs Market, Major End Users

Table 11: Global Asthma Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Asthma Drugs Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Asthma Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Asthma Drugs Market - TAM, US$ Billion, 2025

Table 15: Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Asia-Pacific, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: China, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: India, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: Japan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Australia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Indonesia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: South Korea, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: Taiwan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: South East Asia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: Western Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: UK, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: Germany, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: France, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: Italy, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Spain, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Eastern Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Russia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: North America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: USA, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: Canada, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: South America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: Brazil, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Middle East, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Africa, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Global Asthma Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 97: Global Asthma Drugs Market - Company Scoring Matrix

Table 98: Pfizer Inc. Financial Performance

Table 99: Roche Holding AG Financial Performance

Table 100: Merck & Co. Inc. Financial Performance

Table 101: Sanofi S.A. Financial Performance

Table 102: AstraZeneca PLC. Financial Performance

Table 103: Global Asthma Drugs Market, Competitive Benchmarking (In USD Billions)

Table 104: Global Asthma Drugs Market, Competitive Dashboard

Table 105: Global Asthma Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 106: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Type Of Asthma, 2025 – 2030

Table 107: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Asthma Trigger Type, 2025 – 2030

Table 108: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

List Of Figures

Figure 1: Global Asthma Drugs Market, Overview Of Key Products - Product Examples

Figure 2: Global Asthma Drugs Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Asthma Drugs Market, Supply Chain Analysis

Figure 4: Global Asthma Drugs Market, Major Raw Material Providers

Figure 5: Global Asthma Drugs Market, Major Resource Providers

Figure 6: Global Asthma Drugs Market, Major Manufacturers (Suppliers)

Figure 7: Global Asthma Drugs Market, Major Distributors And Channel Partners

Figure 8: Global Asthma Drugs Market, Key Technologies & Future Trends

Figure 9: Global Asthma Drugs Market, Major Trends

Figure 10: Global Asthma Drugs Market, Major End Users

Figure 11: Global Asthma Drugs Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Asthma Drugs Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Asthma Drugs Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Asthma Drugs Market - TAM, US$ Billion, 2025

Figure 15: Global Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Asthma Drugs Market, Segmentation By Drug Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Asthma Drugs Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Asthma Drugs Market, Sub-Segmentation Of Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Asthma Drugs Market, Sub-Segmentation Of Non-Allergic, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Asthma Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Asthma Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Asia-Pacific, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: China, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: India, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: Japan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Australia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Indonesia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: South Korea, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: Taiwan, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: South East Asia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: Western Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: UK, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: Germany, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: France, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: Italy, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Spain, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Eastern Europe, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Russia, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: North America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: USA, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: Canada, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: South America, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: Brazil, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Middle East, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Africa, Asthma Drugs Market, Segmentation By Type Of Asthma, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Asthma Drugs Market, Segmentation By Asthma Trigger Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Asthma Drugs Market, Segmentation By Therapy, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Global Asthma Drugs Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 97: Global Asthma Drugs Market - Company Scoring Matrix

Figure 98: Pfizer Inc. Financial Performance

Figure 99: Roche Holding AG Financial Performance

Figure 100: Merck & Co. Inc. Financial Performance

Figure 101: Sanofi S.A. Financial Performance

Figure 102: AstraZeneca PLC. Financial Performance

Figure 103: Global Asthma Drugs Market, Competitive Benchmarking (In USD Billions)

Figure 104: Global Asthma Drugs Market, Competitive Dashboard

Figure 105: Global Asthma Drugs Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 106: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Type Of Asthma, 2025 – 2030

Figure 107: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Asthma Trigger Type, 2025 – 2030

Figure 108: Global, Asthma Drugs Market Size Gain ($ Billion), Segmentation By Therapy, 2025 – 2030

Competitive and Market Trend Analysis of Gastric Cancer Therapy Industry Through 2029

Industry Trends Show Gastrointestinal Therapeutics Market Set to Expand at 5.5% CAGR Until 2029

Key Market Drivers, Trends, and Forecast for the Global Gene-Editing Transfection Chemicals Industry

Outlook for Generic Pharmaceuticals Contract Manufacturing Market: Key Developments and Future Strategies to 2029

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Discover key trends and market dynamics in the Mycobacterium Tuberculosis Market with 2025 insights from The Business Research Company.

Inhalable Drugs Market Report 2026 - Global Outlook – By Product (Aerosol, Dry Powder Formulation, Spray), By Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Other Distribution Channels), By Application (Respir...

Allergic Rhinitis Drugs Market Report 2026 - Global Outlook – By Disease (Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis, Occupational Allergic Rhinitis), By Treatment (Antihistamines, Immunotherapy, Corticoster...

Asthma Spacers Market Report 2026 - Global Outlook – By Product (Aerochamber, Optichamber, Volumatic, Inspirease, Other Products), By Distribution Channels (E-commerce Channels, Retail Pharmacies, Hospital Pharmacies, Ot...

Inhalation And Nasal Spray Generic Drugs Market Report 2026 - Global Outlook – By Drug Class (Corticosteroids, Bronchodilators, Antihistamines, Combinations, Decongestant Sprays), By Indication (Asthma, Chronic Obstructi...

Asthma Drugs Market Report 2026 - Global Outlook – By Type Of Asthma (Allergic, Non-Allergic), By Asthma Trigger Type (Adult-Onset Asthma, Child-Onset Asthma, Cough-Induced Asthma, Exercise-Induced Asthma, Occupational A...

Anti-Asthmatic And COPD Drugs Market 2021 - By Drug Class (Bronchodilators, Monoclonal Antibodies, Anti-Inflammatory Drugs, Combination Drugs), By End User (Asthma Patients, COPD Patients), By Distribution Channel (Gener...

Frequently Asked Questions

How big is the Asthma Drugs Market?

The Asthma Drugs market was valued at $24.93 billion in 2025, increased to $26.3 billion in 2026, and is projected to reach $33.62 billion by 2030. request a sample here

What is the Asthma Drugs market growth?

The global Asthma Drugs market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $33.62 billion by 2035. request a sample here

Who are the key players in Asthma Drugs market?

Some Key Players in the Asthma Drugs market Include, Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries Ltd., Novartis International AG, Mylan N.V., Cipla Limited, Chiesi Farmaceutici S.p.A., Sun Pharmaceutical Industries Limited, Hikma Pharmaceuticals, Mundipharma International Limited, Lupin Limited, Glenmark Pharmaceuticals Limited, Hetero Drugs Limited, Alembic Pharmaceuticals Limited, Sunovion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Beximco Pharmaceuticals Ltd., Innoviva Inc., Vectura Group, Circassia Group PLC, Pulmatrix Inc. . request a sample here

What is the anticipated growth trend for the Asthma Drugs market?

Major trend in this market includes: Product Innovation In The Asthma Drug Market With Launch Of Indacaterol Plus Mometasone. For further insights on this market. request a sample here

Which region has the most growth potential in the Asthma Drugs market?

North America was the largest region in the asthma drugs market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the asthma drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. request a sample here.

Who are the key players in the Asthma Drugs Market Report 2026 market?

Major companies operating in the Asthma Drugs Market Report 2026 market are Major companies operating in the asthma drugs market are Pfizer Inc., Roche Holding AG, Merck & Co. Inc., Sanofi S.A., AstraZeneca PLC., GlaxoSmithKline PLC., Boehringer Ingelh request a sample here.